At the recent annual meeting of the International Myositis Assessment and Clinical Studies Group (IMACS) in Chicago, more than 130 international myositis experts joined in recognizing TMA’s retiring Executive Director Bob Goldberg.
Continue Reading
Lenabasum questions answered
Excitement is building for Corbus Pharmaceutical’s Phase 3 clinical trial testing the safety and effectiveness of their new drug lenabasum in dermatomyositis patients.
Continue Reading
Research grants awarded
The Myositis Association announces the awarding of three new research grants to fund basic and applied investigations in myositis diseases.
Continue Reading
Arimoclomol clinical trial for IBM
There is good news for IBM patients who want to participate in the arimoclomol clinical trial.
Continue Reading
Talking Circles for myositis care partners
The Myositis Association is excited to introduce a new program for care partners called Talking Circles.
Continue Reading